CJC-1295 Research: CJC-1295 (Modified GRF 1-29) has been extensively studied as a growth hormone secretagogue
Translation to human tissue outcomes is not demonstrated
Choose TB-500 when your research interest is broader and more recovery-system oriented
At Everest, we identify and treat both the surface inflammation and the underlying factors, whether structural, metabolic, or lifestyle-related, so healing becomes sustainable, not temporary
Research demonstrates that BPC-157 protects and repairs the gut lining, accelerates healing of gastric ulcers, and reduces inflammation throughout the digestive tract
may cause iron-deficiency anemia Nausea and vomiting particularly with stricturing disease/obstruction Urgency and tenesmus with rectal/colonic involvement Weight loss and malnutrition due to malabsorption, food avoidance, elevated metabolic demand Fever with active inflammation, abscess, or fistula Perianal disease fissures, fistulae, skin tags, abscesses Extraintestinal Manifestations Arthropathy peripheral or axial (enteropathic arthritis, M07.6x) Dermatologic: Erythema nodosum (L52), pyoderma gangrenosum, psoriasis (L40.5) Ocular: Uveitis/iritis (H20.01), episcleritis, scleritis Hepatobiliary: Primary sclerosing cholangitis (K73.2), fatty liver, cholelithiasis Metabolic: Osteopenia/osteoporosis (from steroid use and malabsorption), nephrolithiasis Hematologic: Anemia (iron deficiency, B12/folate deficiency, anemia of chronic disease) When a patient with Crohns disease is admitted with significant weight loss, malnutrition, or protein-calorie deficiency , query the provider to specify the degree of malnutrition (mild, moderate, severe protein-calorie malnutrition)
